Nitazene Control Act of 2025 aims to permanently schedule nitazenes under the Controlled Substances Act.
The Nitazene Control Act of 2025 seeks to amend the Controlled Substances Act by permanently scheduling nitazenes, a class of synthetic opioids. This action is intended to address the proliferation of new analogs, streamline enforcement, and protect public health. The bill specifies that nitazenes, including etonitazene, clonitazene, and others, will be classified under Schedule I due to their high abuse potential and lack of accepted medical use. The legislation also ensures that any research involving these substances must comply with proper registration and scheduling requirements.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.